Société Advanced Oncotherapy PLC London S.E.
Actions
GB00B16JQ761
Equipement et technologie médicale avancés
Cours en clôture
Autres places de cotation
|
||
- GBX | - |
03/05 | Les discussions sur le financement d'Advanced Oncotherapy se poursuivent, les fonds sont retardés | AN |
02/04 | Sareum augmente son offre de vente au détail ; SThree recrute un ancien cadre d'ITV | AN |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 49 | 27/08/14 | |
Director of Finance/CFO | - | 01/10/16 | |
Michael Sinclair
CHM | Chairman | 82 | 16/06/06 |
Jonathan Farr
CTO | Chief Tech/Sci/R&D Officer | - | 14/06/17 |
Ed Lee
COO | Chief Operating Officer | - | 01/02/17 |
David Navas
IRC | Investor Relations Contact | - | - |
Henry Clarke
SEC | Corporate Secretary | - | 19/05/19 |
Bridget Biggar
HRO | Human Resources Officer | - | 01/11/16 |
Graham Pughe
AUD | Comptroller/Controller/Auditor | - | 01/12/12 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 29/09/20 |
Michael Sinclair
CHM | Chairman | 82 | 16/06/06 |
Hans von Celsing
BRD | Director/Board Member | 74 | 26/01/17 |
Director/Board Member | 73 | 01/10/13 | |
Ren Hua Zhang
BRD | Director/Board Member | 58 | 28/08/18 |
Director/Board Member | 72 | 26/04/13 | |
Director/Board Member | 74 | 09/02/17 | |
Chief Executive Officer | 49 | 27/08/14 | |
Stephen Myers
BRD | Director/Board Member | 78 | 26/01/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 542 573 869 | 284 689 154 ( 52,47 %) | 0 | 52,47 % |
Coordonnées société
Advanced Oncotherapy Plc
4 Tenterden Street Third Floor
W1S 1TE, London
+44 20 3617 8728
http://advancedoncotherapy.comSecteur
Ventes par région
Varia. 1 janv. | Capi. | |
---|---|---|
+7,84% | 218 Md | |
+7,35% | 184 Md | |
+13,04% | 135 Md | |
+26,03% | 107 Md | |
-1,33% | 62,38 Md | |
+11,80% | 51,37 Md | |
+4,81% | 50,9 Md | |
+0,30% | 40,87 Md | |
+2,78% | 36,28 Md |
- Bourse
- Actions
- Action AVO
- Action
- Société Advanced Oncotherapy PLC